These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8769233)

  • 1. Incidence of cytomegalovirus infection in kidney recipients.
    Bilgin N; Karakayali H; Moray G; Akkoç H; Turan M
    Transplant Proc; 1996 Aug; 28(4):2314-5. PubMed ID: 8769233
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of cytomegalovirus infection in kidney recipients.
    Cuhadaroğlu S; Tokyay R; Velidedeoğlu E; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1924-5. PubMed ID: 1329288
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 4. Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study.
    Legendre C; Ducloux D; Ferroni A; Chkoff N; Valette C; Geffrier C; Rouzioux C; Kreis H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1431-3. PubMed ID: 8382871
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of cytomegalovirus infection in renal transplant recipients in Korea.
    Kahng KW; Kang CM; Kwak JY
    Transplant Proc; 1996 Jun; 28(3):1507. PubMed ID: 8658762
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased late rejection in cytomegalovirus-immunoglobulin-M-positive heart transplantation patients.
    Bunke M; Ganzel B; Gardner C
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):44-5. PubMed ID: 7482819
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration.
    Haberal M; Velidedoğlu E; Arslan G; Bilgin N; Büyükpamukçu N; Karamehmetoğlu M
    Transplant Proc; 1995 Oct; 27(5):2707. PubMed ID: 7482883
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic cytomegalovirus infection in renal transplants: treatment or no treatment.
    Lee PC; Hung CJ; Sung JM; Chang YT; Tsai MT; Dai YS; Liang CC; Lei HY
    Transplant Proc; 1996 Jun; 28(3):1513-5. PubMed ID: 8658765
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients.
    Yeung S; Tong KL; Chan HW
    Transplant Proc; 2000 Nov; 32(7):1928-9. PubMed ID: 11120005
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus infection in renal allograft recipients in Taiwan.
    Hu RH; Lee PH; Huang MT; Chung YC; Lee CS
    Transplant Proc; 1994 Aug; 26(4):2034-5. PubMed ID: 8066662
    [No Abstract]   [Full Text] [Related]  

  • 12. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.
    van Son WJ; van den Berg AP; The TH; Tegzess AM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1436-8. PubMed ID: 8382873
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of cytomegalovirus antibody status on graft survival in renal transplantation.
    Fauchald P; Leivestad T; Rollag H; Albrechtsen D; Sødal G
    Transplant Proc; 1994 Jun; 26(3):1725. PubMed ID: 8030103
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic diagnostic and therapeutic aspects of cytomegalovirus, human herpes virus-6, and Epstein-Barr virus disease posttransplantation.
    Jacobs U; Eis-Hübinger A; Dietrich Miersch W; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3238. PubMed ID: 8962253
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric renal transplantation in a single center from Brazil.
    Abbud-Filho M; Ramalho H; Barberato JB; Silva ML; Yamazaki W; Salgueiro MC; Zerati-Fo M; D'Avila CL; Bezas AG
    Transplant Proc; 1995 Apr; 27(2):1834. PubMed ID: 7725526
    [No Abstract]   [Full Text] [Related]  

  • 16. Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients.
    Prokurat S; Drabik E; Grenda R; Vogt E
    Transplant Proc; 1993 Aug; 25(4):2577. PubMed ID: 8395104
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation from cadaveric and living donors.
    Lo CM; Lo RJ; Lai CL; Fan ST; Wong J
    Transplant Proc; 1996 Jun; 28(3):1659-60. PubMed ID: 8658826
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation.
    Munoz MA; Andrés A; Gallego R; Morales E; Morales JM; Aguado JM; Lumbreras C; Torres A; Rodicio JL; Praga M
    Transplant Proc; 2002 Feb; 34(1):97. PubMed ID: 11959202
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection.
    Neumann UP; Knoop M; Langrehr JM; Jonas S; Bechstein WO; Lang M; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2859-60. PubMed ID: 9365592
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cytomegalovirus infection on renal function in kidney transplant recipients.
    Choi SJ; Kim NH; Cho CK; Chung SY; Kim HJ; Choi KC; Kim SK
    Transplant Proc; 1996 Jun; 28(3):1523-4. PubMed ID: 8658769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.